Biogen's MS Pill Roars Out Of Launch Gate
TheStreet.com
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Battle Lines Drawn in the MS Market
Motley Fool
JAMA says FDA jumped the gun on Gilenya, Pradaxa
Fierce Pharma
Your Warning Label Is My Sales Brochure
Motley Fool
Novartis limits use of Copaxone rival Gilenya
Globes, Israel
Watchdog says FDA should consider restricting Gilenya
Fierce Pharma

